Cipher Pharmaceuticals Reports Q2 2018 Results

XERMELO® (telotristat ethyl) 2018 U.S. Net Sales Reached $25.0 Million Sotagliflozin i.....»»

Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update.....»»

PLYMOUTH MEETING, Pa., March 12, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted again.....»»

DEVON, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innova.....»»

DEVON, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pha.....»»

Conference Call to be Held at 8:00 am Eastern TimeInarigivir Late-Breaker Abstract Accepted for Oral Presentation at EASL The International Liver Congress 2019 HOPKINTON, Mass.,.....»»

Conference Call to be Held at 8:00 am Eastern TimeInarigivir Late-Breaker Abstract Accepted for Oral Presentation at EASL The International Liver Congress 2019 HOPKINTON, Mass.,.....»»

SAN DIEGO, March 08, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) today.....»»

BOSTON, March 08, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYT.....»»

Eloxx announces the hiring of Dr. Susan Schneider as SVP Ophthalmology to lead the development of its rare inherited retinal disease programs Abstract acce.....»»

ROCKVILLE, Md., March 08, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE:RNN), a clinical stage biopharmaceutical co.....»»

Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update.....»»

Cipher Pharmaceuticals Provides Corporate Update and Preliminary .....»»

Investors are expected to focus on Eylea's performance and Dupixent's uptake when Regeneron Pharmaceuticals, Inc. (REGN) reports first-quarter 2018 results on May 3. .....»»

TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC:POLXF) (the "Company") reports financial results for its fiscal year ended January 31, 2018. All figures a.....»»

ANI Pharmaceuticals Reports F.....»»

EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results.....»»

Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides .....»»

Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results.....»»

-- New drug applications for omadacycline accepted for priority review by FDA; PDUFA action date in October 2018.....»»